Skip Navigation



IJE Advance Access published online on October 12, 2009
International Journal of Epidemiology, doi:10.1093/ije/dyp307
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by El-Zein, M.
Right arrow Articles by Rousseau, M.-C.
PubMed
Right arrow PubMed Citation
Right arrow Articles by El-Zein, M.
Right arrow Articles by Rousseau, M.-C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published by Oxford University Press on behalf of the International Epidemiological Association © The Author 2009; all rights reserved.

Does BCG vaccination protect against the development of childhood asthma? A systematic review and meta-analysis of epidemiological studies

Mariam El-Zein1,*, Marie-Elise Parent1, Andrea Benedetti2 and Marie-Claude Rousseau1

1INRS-Institut Armand-Frappier, Institut national de la recherche scientifique, Laval, Quebec, Canada.
2Department of Medicine and Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec, Canada.

* Corresponding author. INRS-Institut Armand-Frappier, Institut national de la recherche scientifique, 531, boul. des Prairies, Laval, Quebec H7V 1B7, Canada. E-mail: mariam.elzein{at}iaf.inrs.ca


  Abstract

Background Results have been conflicting as to whether Bacillus Calmette-Guérin (BCG) vaccine, a non-specific stimulator of the immune function, protects, predisposes or is unrelated to the development of childhood asthma. In this systematic review and meta-analysis, we qualitatively and quantitatively appraised the epidemiological evidence.

Methods Eligible studies were identified using a search strategy that included a computerized literature search and a manual search of each article's reference list, up to June 2008. A total of 23 studies were included (10 cohort, 5 case–control and 8 cross-sectional). Each study was summarized and rated for methodological quality. Pooled odds ratio (OR) estimates and 95% confidence intervals (CIs) were calculated using fixed-effects (FE) or random-effects (RE) models; if heterogeneity was present, the latter was used. Three indicators of BCG exposure were considered including BCG vaccination, tuberculin response and scar diameter.

Results The pooled estimate of association for 23 studies reporting on any of the three indicators suggested a protective effect of BCG exposure on childhood asthma occurrence. The studies were heterogeneous, especially when tuberculin response was considered. Restriction to a subgroup of 16 studies that considered BCG vaccination indicated a protective effect with no evidence of heterogeneity. The overall pooled OR using an FE model was 0.86 (95% CI 0.79–0.93). Exclusion of three studies with the lowest quality scores showed a similar association.

Conclusion These results strengthen the epidemiological evidence in support of the hypothesis that exposure to the BCG vaccine in early life prevents asthma, possibly through a modulation of the immune maturation process.

Keywords Asthma, BCG vaccine, child, meta-analysis, review, tuberculin

Accepted 26 August 2009


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.